Hansen Carl L. G. 4
4 · AbCellera Biologics Inc. · Filed Nov 26, 2024
Insider Transaction Report
Form 4
Hansen Carl L. G.
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Common Shares
2024-11-25$2.70/sh+56,125$151,538→ 898,000 total - Exercise/Conversion
Share option (right to buy)
2024-11-25−56,125→ 8,260,223 totalExercise: $2.70Exp: 2030-11-27→ Common Shares (56,125 underlying)
Holdings
- 56,086,009(indirect: See footnote)
Common Shares
Footnotes (2)
- [F1]These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person.
- [F2]The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.